Navigation Links
Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454
Date:5/2/2008

reclinical and clinical research organizations, manufacturers and consultants; protecting the intellectual property developed by or licensed to Memory Pharmaceuticals; and Memory Pharmaceuticals' ability to maintain listing on the Nasdaq Global Market. These and other risks are described in greater detail in Memory Pharmaceuticals' filings with the Securities and Exchange Commission. Memory Pharmaceuticals may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Memory Pharmaceuticals disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.


'/>"/>
SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
2. MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
3. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
4. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
5. Roche responds to announcement of IDEAL hepatitis C trial results
6. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
7. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
8. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
9. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
10. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
11. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Restore Health, a ... compounded pharmaceuticals, announced that it is now offering ... to each individual based upon their particular genetic ... understanding the interaction between a patient,s genetics and ... very excited to provide this new service to ...
(Date:7/24/2014)... 24, 2014  Abaxis, Inc. (NasdaqGS: ABAX ... systems, today reported financial results for the first fiscal ... overview: , Revenues of $47.5 million, up 10% ... of $0.21, up 50% over last year,s comparable quarter. ... of $7.2 million, up 20% over last year,s comparable ...
(Date:7/24/2014)... 24, 2014 Omnicell, Inc. (NASDAQ: ... and supply management solutions and analytics software for ... 31, to discuss the Company,s Second Quarter 2014 ... 2014 earnings conference call and webcastWhen: , ... Lipps, chairman, president and chief executive officer ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
... Food and Drug Administration (FDA) says children and pets should not come in contact with ... menopause. , , , ... , , ... , The agency also wants ...
... AUSTIN, Texas ,  July 29 Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics ... issuance of Q2 financial results on Monday, August 16, 2010 . , ... Conference Call Information , , ... live conference call via phone, dial (800) 757 8521 from the United States ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION - Keep Kids, Pets Away From Skin Sprayed With Evamist 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 3
(Date:7/26/2014)... July 26, 2014 The report “Gourmet ... Himalayan Salt, Flake Salt, Specialty Salt), Application (Bakery & ... Savory) & Geography - Global Trend & Forecast to ... analyses and projection of the market size in terms ... and restraining factors for the gourmet salts market, with ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 The European gas ... Europe with analysis and forecast of revenue. The gas chromatography ... in 2013, and is estimated to grow to around $445.5 ... 2013 to 2018. , Browse through the TOC of the ... the in-depth analysis provided. This report also provides a glimpse ...
(Date:7/26/2014)... “Today, we introduce our new items of ... the world. All these models are offered at discounted ... UK market,” says the CEO of the company. DressesOnlineShops.co.uk ... special occasion outfits. , Ladies have to find a ... one of the best choices for many ladies worldwide ...
(Date:7/26/2014)... 26, 2014 According to ... by Vkool.com, this is a comprehensive guide ... for treating all types of disorders ...     Tinnitus due to Ménière's disease , ...     Nerve pathway tinnitus ,     Inner, middle ...
(Date:7/26/2014)... ON (PRWEB) July 26, 2014 Studio B ... type of implant, often called Teeth in a Day, gives ... with a full set of bright, pearly whites with very ... teeth are permanent, look and feel just like natural teeth, ... and regular checkups. Studio B Dental is one of ...
Breaking Medicine News(10 mins):Health News:Gourmet Salts Market Worth $1,340.9 Million by 2019 - Report by MarketsandMarkets 2Health News:Gourmet Salts Market Worth $1,340.9 Million by 2019 - Report by MarketsandMarkets 3Health News:Gourmet Salts Market Worth $1,340.9 Million by 2019 - Report by MarketsandMarkets 4Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 5Health News:Famous Supplier DressesOnlineShops.co.uk Announces Its New Selection of Prom Dresses for the UK Market 2Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2Health News:Studio B Dental Improves Patient Smiles with All-on-Four Dental Implants 2
... of the latest fleet golf car and the role ... a leader in,manufacturing execution systems (MES) for the integrated ... event,titled "Launching the E-Z-GO Fleet Golf Car: Integrating Manufacturing,Execution ... place on Thursday, March 6, 2008 at 2:00 p.m. ...
... accuracy with Microsoft Dynamics ... ... AliMed, a producer and catalog-based distributor of medical,products, has chosen Microsoft ... business and expanding its interaction with,customers. The technology will enable AliMed ...
... DENVER, March 4 Global Med Technologies(R),Inc. ... GLOB), an,international e-Health, medical information technology company, will ... Monday, March 10, 2008, before,the market open. The ... p.m. EDT,on the same day., (Logo: ...
... or tablets avoid the pain and side effects of shots, ... allergy immunotherapy -- in the form of drops or tablets ... for asthma medications in children who have what,s known as ... hopes that these oral medications might someday replace injections, never ...
... March 4 The number of Arab,Americans is ... second largest,concentration of people of Arab descent outside ... grows, so do their healthcare needs. Like many,other ... and educational challenges in accessing health information and,care., ...
... Patient Citizens Promotes National Kidney Month Programs to,Combat ... Nationwide -, WASHINGTON, March 4 DaVita ... comprised of more than 22,000,dialysis and pre-dialysis patients ... life for all dialysis patients through education and,advocacy ...
Cached Medicine News:Health News:E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek 2Health News:E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek 3Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 2Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 3Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 4Health News:Medical Products Distributor Gains New Flexibility With Its Selection of Microsoft Dynamics AX and Microsoft Dynamics CRM 5Health News:Global Med Technologies(R), Inc. to Announce Fourth Quarter and Year End Results on Monday, March 10, 2008 2Health News:Global Med Technologies(R), Inc. to Announce Fourth Quarter and Year End Results on Monday, March 10, 2008 3Health News:Oral Allergy Immunotherapy Helps Control Asthma 2Health News:Oral Allergy Immunotherapy Helps Control Asthma 3Health News:International and Domestic Leaders to Convene to Tackle Health Issues in the Arab American Community 2Health News:Kidney Patient Advocacy Community Joins National Effort to Raise Awareness about Health Crisis Impacting more than 26 Million Americans 2
Straight chisel for scoring, cutting, scraping, cleaning and sculpting bone....
Custom-made chisels....
Lewin Bone Forceps, serrated and slightly curved. To hold, stabilize, rotate, reduce and,compress bone....
To elevate, dissect, scrape and apply traction to bone and soft tissue....
Medicine Products: